Applicability of Outpatient Quality Indicators for Appropriate Antibiotic Use in a Primary Health Care Area: a Point Prevalence Survey-Reference-Cited by-同舟云学术

Applicability of Outpatient Quality Indicators for Appropriate Antibiotic Use in a Primary Health Care Area: a Point Prevalence Survey

Published:2020-10-20 Issue:11 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

March-López Pablo¹²³^ORCID,Madridejos Rosa²,Tomas Rosa²,Boix-Palop Lucía³⁴,Arcenillas Paula¹,Gómez Lucía⁴,Padilla Emma⁵^ORCID,Xercavins Mariona⁵,Martinez Laura¹,Massats Úrsula⁶,Badia Cristina⁶,Lledó Joan Manuel Sánchez⁷,Casino Alberto Domingo⁷,Nicolás Jordi¹⁸,Calbo Esther³⁴^ORCID

Affiliation:

1. Hospital Pharmacy, Pharmacy Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain

2. Primary Care Pharmacy, Pharmacy Department, Mútua Terrassa, Barcelona, Spain

3. School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain

4. Infectious Diseases Unit, Hospital Universitari Mútua Terrassa, Barcelona, Spain

5. Microbiology Department, CATLAB, Barcelona, Spain

6. Infection Control Nurse, Hospital Universitari Mútua Terrassa, Barcelona, Spain

7. Information Systems, Mútua Terrassa, Barcelona, Spain

8. Universitat de Barcelona, Barcelona, Spain

Abstract

The ability to measure the quality of antibiotic prescriptions is a critical element in all antimicrobial stewardship programs. The aims of the present study were to evaluate the clinimetric properties of 32 recently developed outpatient quality indicators (OQIs) and to identify potential room for improvement in antibiotic use in a primary health care (PHC) area. The study was performed in a PHC area in Barcelona, Spain with 260,657 inhabitants, nine PHC centers, and a 400-bed acute-care teaching hospital.

Funder

Astellas Pharma

Pfizer

Merck & Co., Inc. | Merck Sharp and Dohme

AstraZeneca

Novartis

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01266-20

Reference32 articles.

1. World Health Organization. 2014. Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, Switzerland. https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=16C633BA216FD209B181D04BA2C09E87?sequence=1.

2. Antibiotic resistance threats in the United States, 2019

3. The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

4. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

5. European Centre for Disease Prevention and Control. 2018. Antimicrobial consumption. ECDC annual epidemiological report for 2017. Stockholm Sweden. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-antimicrobial-consumption.pdf.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point prevalence audit surveys of respiratory tract infection consultations and antibiotic prescribing in primary care before and during the COVID-19 pandemic in Ireland;Journal of Antimicrobial Chemotherapy;2023-03-28